Acadia Healthcare公布2024年第一季度业绩，确认2024年全年指导意见-动脉网

Acadia Healthcare Reports First Quarter 2024 Results, Affirms Full Year 2024 Guidance

businesswire 等信源发布 2024-05-02 02:05



可切换为仅中文







FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2024.

田纳西州富兰克林（BUSINESS WIRE）--阿卡迪亚医疗保健公司（NASDAQ:ACHC）今天公布了截至2024年3月31日的第一季度财务报表。

First Quarter Highlights

第一季度亮点

Revenue totaled $768.1 million, an increase of 9.1% over the first quarter of 2023

收入总计7.681亿美元，比2023年第一季度增长9.1%

Same facility revenue increased 9.2% compared with the first quarter of 2023, including an increase in revenue per patient day of 6.9% and an increase in patient days of 2.2%

与2023年第一季度相比，同一设施的收入增加了9.2%，其中每病人日收入增加了6.9%，病人日增加了2.2%

Net income attributable to Acadia totaled $76.4 million, or $0.83 per diluted share

归属于Acadia的净收入总计7640万美元，或稀释后每股0.83美元

Adjusted income attributable to Acadia totaled $77.3 million, or $0.84 per diluted share

归属于Acadia的调整后收入总计7730万美元，或稀释后每股0.84美元

Adjusted EBITDA totaled $173.9 million, an increase of 14.9% over the first quarter of 2023

调整后的息税折旧摊销前利润总计1.739亿美元，比2023年第一季度增长14.9%

Adjusted EBITDA margin of 22.6%, an increase of 110 basis points over the first quarter of 2023

调整后的息税折旧摊销前利润率为22.6%，比2023年第一季度增加了110个基点

Continued progress on the execution of the Company’s growth strategy, including the addition of 27 beds to the Company’s existing facilities and through opening one new specialty de novo facility and acquiring one specialty provider and three comprehensive treatment centers (“CTCs”)

公司发展战略的执行继续取得进展，包括在公司现有设施中增加27张病床，并通过开设一家新的专业新生设施，收购一家专业供应商和三家综合治疗中心（“CTC”）

Opened a 100-bed acute care hospital in Mesa, Arizona, in April 2024.

2024年4月，在亚利桑那州梅萨开设了一家拥有100张床位的急救医院。

Adjusted income attributable to Acadia and Adjusted EBITDA are non-GAAP financial measures. A reconciliation of all non-GAAP financial measures in this press release begins on page 9.

归属于Acadia的调整后收入和调整后息税折旧摊销前利润是非GAAP财务指标。本新闻稿中所有非公认会计准则财务指标的对账从第9页开始。

First Quarter Results

第一季度业绩

Chris Hunter, Chief Executive Officer of Acadia Healthcare Company, remarked, “We are pleased with our solid financial and operating performance for the first quarter of 2024, with year-over-year top line growth of 9.1%. Strong operating leverage, including continued improvement in our labor trends, helped drive year-over-year EBITDA growth of 14.9%.

Acadia Healthcare Company首席执行官克里斯·亨特（ChrisHunter）表示：“我们对2024年第一季度稳健的财务和经营业绩感到满意，同比增长9.1%。强大的经营杠杆，包括劳动力趋势的持续改善，推动了EBITDA同比增长14.9%。

Overall, we continue to see a robust need for our behavioral health services and remain confident in our ability to meet our strategic growth objectives in 2024, including the addition of approximately 1,200 new beds this year. With a proven operating model, a patient-centric approach across the continuum of care, and a strong focus on clinical quality, we are well positioned to meet expected demand and continue to provide safe, quality patient care for those seeking treatment for mental health and substance use issues.”.

总的来说，我们继续看到对行为健康服务的强烈需求，并对我们在2024年实现战略增长目标的能力保持信心，包括今年新增约1200张床位。凭借行之有效的运营模式，在整个护理过程中以患者为中心的方法，以及对临床质量的高度关注，我们完全有能力满足预期需求，并继续为寻求心理健康和药物使用问题治疗的患者提供安全，优质的患者护理。”。

Strategic Investments for Long-Term Growth

长期增长战略投资

During the first quarter of 2024, the Company continued to advance its growth strategy with the following accomplishments through its five distinct growth pathways.

2024年第一季度，公司通过五条不同的增长途径，继续推进其增长战略，取得了以下成就。

Facility Expansions – Added 27 beds to existing facilities in the first quarter. The Company expects to add more than 400 beds to existing facilities in 2024.

设施扩建——第一季度在现有设施的基础上增加了27张床位。该公司预计到2024年将在现有设施中增加400多张床位。

De Novo Facilities – Opened a new 20-bed specialty facility, Sabal Palms Recovery Center, located near Tampa, Florida, that will provide residential addiction treatment services. Following the end of the quarter, Acadia opened a new 100-bed acute care hospital, Agave Ridge Behavioral Hospital, in Mesa, Arizona..

De Novo Facilities–在佛罗里达州坦帕附近开设了一家拥有20张床位的新专业设施Sabal Palms康复中心，该中心将提供住宿成瘾治疗服务。本季度结束后，阿卡迪亚在亚利桑那州梅萨开设了一家新的100张床位的急救医院——龙舌兰岭行为医院。。

Joint Ventures – In January, Acadia announced a new joint venture partnership with Ascension Seton, one of the nation’s leading integrated healthcare systems, for a behavioral health hospital in Austin, Texas. This hospital, expected to open later in 2024, marks the Company’s second joint venture partnership with Ascension.

合资企业——今年1月，阿卡迪亚宣布与美国领先的综合医疗系统之一阿森松塞顿（Ascension Seton）在德克萨斯州奥斯汀的一家行为健康医院建立新的合资伙伴关系。这家医院预计将于2024年晚些时候开业，标志着该公司与阿森松岛（Ascension）的第二次合资伙伴关系。

During the quarter, the Company also commenced construction on two new hospitals, holding ground-breaking ceremonies in Apopka, Florida, in partnership with Orlando Health, and in Malden, Massachusetts, in partnership with Tufts Medicine. Acadia has 21 joint venture partnerships for 22 hospitals, with 11 hospitals already in operation and 11 additional hospitals expected to open over the next few years..

本季度，该公司还开始建造两家新医院，与奥兰多健康公司（Orlando Health）合作在佛罗里达州的阿波普卡（Apopka）和与塔夫茨医学公司（Tufts Medicine）合作在马萨诸塞州的马尔登（Malden）举行了奠基仪式。Acadia为22家医院建立了21家合资伙伴关系，其中11家医院已投入运营，另外11家医院预计将在未来几年内开业。。

Acquisitions – In February, the Company closed the previously announced acquisition of Turning Point Centers, a 76-bed specialty provider of substance use disorder and primary mental health treatment services that supports the Salt Lake City, Utah, metropolitan market. In March, the Company completed the acquisition of three CTCs in North Carolina, serving patients in Raleigh, Greenville, Hillsborough, and their respective surrounding communities.

收购–2月，该公司完成了之前宣布的对转折点中心（Turning Point Centers）的收购，转折点中心是一家拥有76张床位的物质使用障碍和初级心理健康治疗服务专业提供商，为犹他州盐湖城大都会市场提供支持。3月，该公司完成了对北卡罗来纳州三家CTC的收购，为罗利、格林维尔、希尔斯堡及其周边社区的患者提供服务。

With these additions, Acadia now operates 10 CTC locations in North Carolina and 160 locations in 32 states across the country..

通过这些新增项目，阿卡迪亚目前在北卡罗莱纳州运营10个反恐中心，在全国32个州运营160个反恐中心。。

Extend Continuum of Care – Expanded treatment options by adding 15 outpatient programs during the first quarter. These programs include Partial Hospitalization Programs (PHP), Intensive Outpatient Programs (IOP) or virtual services.

扩展连续护理–通过在第一季度增加15个门诊项目来扩大治疗选择。这些计划包括部分住院计划（PHP），强化门诊计划（IOP）或虚拟服务。

Cash and Liquidity

现金和流动性

Acadia has continued to maintain a strong financial position with sufficient capital to make strategic investments in its business. As of March 31, 2024, the Company had $77.3 million in cash and cash equivalents and $371.5 million available under its $600 million revolving credit facility with a net leverage ratio of approximately 2.6x..

阿卡迪亚继续保持强大的财务状况，拥有足够的资本对其业务进行战略投资。截至2024年3月31日，该公司拥有7730万美元的现金和现金等价物，在其6亿美元的循环信贷额度下有3.715亿美元可用，净杠杆率约为2.6倍。。

Net leverage ratio is a non-GAAP financial measure. A reconciliation of all non-GAAP financial measures in this press release begins on page 9.

净杠杆率是一种非GAAP财务指标。本新闻稿中所有非公认会计准则财务指标的对账从第9页开始。

Financial Guidance

财务指导

Acadia today affirmed its previously announced financial guidance for 2024, as follows:

Acadia今天确认了其先前宣布的2024年财务指导，如下所示：

2024 Guidance Range

2024制导范围

Revenue (1)

收入（1）

$3.18 to $3.25 billion

31.8亿至32.5亿美元

Adjusted EBITDA (1)

调整后息税折旧摊销前利润（1）

$730 to $770 million

7.3亿至7.7亿美元

Adjusted earnings per diluted share (1)

调整后稀释每股收益（1）

$3.40 to $3.70

3.40至3.70美元

Interest expense

利息支出

$110 to $120 million

1.1亿至1.2亿美元

Tax rate

税率

24.5% to 25.5%

24.5%至25.5%

Depreciation and amortization expense

折旧和摊销费用

$150 to $160 million

1.5亿至1.6亿美元

Stock compensation expense

股票补偿费用

$40 to $45 million

4000万至4500万美元

Operating cash flows

经营现金流

$525 to $575 million

5.25亿至5.75亿美元

Expansion capital expenditures

扩张资本支出

$425 to $475 million

4.25亿至4.75亿美元

Maintenance and IT capital expenditures

维护和IT资本支出

$90 to $110 million

9000万至1.1亿美元

Total bed additions, excluding acquisitions

总床位增加，不包括收购

Approx. 1,200 beds

约1200张床位

(1)

Includes one-time payments from a state of approximately $10 million (or $0.09 per diluted share) for the year, of which approximately $7 million (or $0.06 per diluted share) was received in the first quarter of 2024.

包括本年度约1000万美元（或稀释后每股0.09美元）的一次性付款，其中约700万美元（或稀释后每股0.06美元）在2024年第一季度收到。

The Company’s guidance does not include the impact of any future acquisitions, divestitures, transaction, legal and other costs or non-recurring legal settlements expense.

公司指南不包括任何未来收购、资产剥离、交易、法律和其他成本或非经常性法律结算费用的影响。

Conference Call

电话会议

Acadia will hold a conference call to discuss its first quarter financial results at 8:00 a.m. Central/9:00 a.m. Eastern Time on Thursday, May 2, 2024. A live webcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the conference call will be available for 30 days..

Acadia将于2024年5月2日（星期四）上午8:00（中部时间）/上午9:00（东部时间）召开电话会议，讨论其第一季度财务业绩。电话会议的在线直播将在www.acadiahealthcare.com的网站“投资者”部分提供。电话会议的网络广播将持续30天。。

About Acadia

关于阿卡迪亚

Acadia is a leading provider of behavioral healthcare services across the United States. As of March 31, 2024, Acadia operated a network of 258 behavioral healthcare facilities with approximately 11,300 beds in 38 states and Puerto Rico. With approximately 23,500 employees serving more than 75,000 patients daily, Acadia is the largest stand-alone behavioral healthcare company in the U.S.

Acadia是美国行为保健服务的领先提供商。截至2024年3月31日，Acadia在38个州和波多黎各运营了258家行为医疗机构，拥有约11300张床位。Acadia拥有约23500名员工，每天为75000多名患者提供服务，是美国最大的独立行为保健公司。

Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics..

Acadia在各种环境中为患者提供行为保健服务，包括住院精神病医院、专科治疗设施、住院治疗中心和门诊诊所。。

Forward-Looking Information

前瞻性信息

This press release contains forward-looking statements. Generally, words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” and “believe” or the negative of or other variation on these and other similar expressions identify forward-looking statements.

本新闻稿包含前瞻性声明。一般来说，诸如“可能”、“将”、“应该”、“可能”、“预期”、“期望”、“打算”、“估计”、“计划”、“继续”和“相信”等词语，或者这些和其他类似表达的否定或其他变化，都可以识别前瞻性陈述。

These forward-looking statements are made only as of the date of this press release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are based on current expectations and involve risks and uncertainties and our future results could differ significantly from those expressed or implied by our forward-looking statements.

这些前瞻性声明仅在本新闻稿发布之日做出。我们不承诺因新信息、未来事件或其他原因而更新或修订前瞻性声明。前瞻性陈述基于当前的预期，涉及风险和不确定性，我们未来的结果可能与前瞻性陈述所表达或暗示的结果有很大差异。

Factors that may cause actual results to differ materially include, without limitation, (i) potential difficulties in successfully integrating the operations of acquired facilities or realizing the expected benefits and synergies of our facility expansions, acquisitions, joint ventures and de novo transactions; (ii) Acadia’s ability to add beds, expand services, enhance marketing programs and improve efficiencies at its facilities; (iii) potential reductions in payments received by Acadia from government and commercial payors; (iv) the occurrence of patient incidents, governmental investigations, litigation and adverse regulatory actions, which could adversely affect the price of our common stock and result in substantial payments and incremental regulatory burdens; (v) the risk that Acadia may not generate sufficient cash from operations to service its debt and meet its working capital and capital expenditure requirements; (vi) potential disruptions to our information technology systems or a cybersecurity incident; and (vii) potential .

可能导致实际结果产生重大差异的因素包括但不限于：（i）成功整合收购设施的运营或实现我们设施扩建、收购、合资企业和从头交易的预期利益和协同作用方面的潜在困难；（ii）Acadia增加床位、扩大服务、加强营销计划和提高设施效率的能力；（iii）Acadia从政府和商业付款人收到的付款可能减少；（iv）患者事件、政府调查、诉讼和不利监管行为的发生，可能对我们的普通股价格产生不利影响，并导致大量付款和增加监管负担；（v）阿卡迪亚可能无法从运营中产生足够的现金来偿还债务并满足其营运资本和资本支出要求的风险；（vi）我们的信息技术系统可能受到干扰或网络安全事件；（vii）潜力。

Acadia Healthcare Company, Inc.

阿卡迪亚医疗保健公司。

Condensed Consolidated Statements of Operations

简明合并经营报表

(Unaudited)

（未经审计）

Three Months Ended March 31,

截至3月31日的三个月，

2024

2023

(In thousands, except per share amounts)

（单位：千，每股金额除外）

Revenue

收入

768,051

704,267

Salaries, wages and benefits (including equity-based compensationexpense of $8,678 and $7,629, respectively)

工资、工资和福利（包括股权薪酬支出分别为8678美元和7629美元）

417,523

391,177

Professional fees

专业费用

45,688

41,125

Supplies

供应品

26,652

26,021

Rents and leases

租金和租赁

11,863

11,424

Other operating expenses

其他营业费用

101,073

90,838

Depreciation and amortization

折旧和摊销

36,347

31,569

Interest expense, net

利息支出净额

27,214

19,999

Transaction, legal and other costs

交易、法律和其他成本

2,847

6,471

Total expenses

总费用

669,207

618,624

Income before income taxes

所得税前收入

98,844

85,643

Provision for income taxes

所得税准备金

20,074

19,085

Net income

净收入

78,770

66,558

Net income attributable to noncontrolling interests

归属于非控股权益的净收入

(2,387

)

(543

)

Net income attributable to Acadia Healthcare Company, Inc.

归属于Acadia Healthcare Company，Inc.的净收入。

76,383

66,015

Earnings per share attributable to Acadia Healthcare Company, Inc.stockholders:

归属于Acadia Healthcare Company，Inc.股东的每股收益：

Basic

基本

0.84

0.73

Diluted

稀释

0.83

0.72

Weighted-average shares outstanding:

加权平均流通股：

Basic

基本

91,363

90,101

Diluted

稀释

92,010

91,391

Acadia Healthcare Company, Inc.

阿卡迪亚医疗保健公司。

Condensed Consolidated Balance Sheets

简明合并资产负债表

(Unaudited)

（未经审计）

March 31,

3月31日，

December 31,

12月31日，

2024

2023

(In thousands)

（单位：千）

ASSETS

资产

Current assets:

流动资产：

Cash and cash equivalents

现金及现金等价物

77,303

100,073

Accounts receivable, net

应收账款净额

386,191

361,451

Other current assets

其他流动资产

147,312

134,476

Total current assets

流动资产总额

610,806

596,000

Property and equipment, net

财产和设备净值

2,376,059

2,266,610

Goodwill

商誉

2,261,026

2,225,962

Intangible assets, net

无形资产净值

73,352

73,278

Deferred tax assets

递延所得税资产

2,777

6,658

Operating lease right-of-use assets

经营租赁使用权资产

121,346

117,780

Other assets

其他资产

71,881

72,553

Total assets

总资产

5,517,247

5,358,841

LIABILITIES AND EQUITY

负债和权益

Current liabilities:

流动负债：

Current portion of long-term debt

长期债务的流动部分

61,452

29,219

Accounts payable

应付账款

156,130

156,132

Accrued salaries and benefits

应计工资和福利

118,005

141,901

Current portion of operating lease liabilities

经营租赁负债的流动部分

26,815

26,268

Other accrued liabilities

其他应计负债

119,911

532,261

Total current liabilities

流动负债合计

482,313

885,781

Long-term debt

长期债务

1,794,296

1,342,548

Deferred tax liabilities

递延所得税负债

15,527

1,931

Operating lease liabilities

经营租赁负债

103,352

100,808

Other liabilities

其他负债

146,404

140,113

Total liabilities

负债总额

2,541,892

2,471,181

Redeemable noncontrolling interests

可赎回非控股权益

109,333

105,686

Equity:

股权：

Common stock

普通股

916

913

Additional paid-in capital

额外实收资本

2,657,002

2,649,340

Retained earnings

留存收益

208,104

131,721

Total equity

总股本

2,866,022

2,781,974

Total liabilities and equity

负债和权益合计

5,517,247

5,358,841

Acadia Healthcare Company, Inc.

阿卡迪亚医疗保健公司。

Condensed Consolidated Statements of Cash Flows

简明合并现金流量表

(Unaudited)

（未经审计）

Three Months Ended March 31,

截至3月31日的三个月，

2024

2023

(In thousands)

（单位：千）

Operating activities:

经营活动：

Net income

净收入

78,770

66,558

Adjustments to reconcile net income to net cash (used in) provided by operating activities:

将净收入调整为经营活动产生的净现金（用于）：

Depreciation and amortization

折旧和摊销

36,347

31,569

Amortization of debt issuance costs

债务发行成本摊销

1,016

824

Equity-based compensation expense

股权薪酬支出

8,678

7,629

Deferred income taxes

递延所得税

17,476

212

Other

其他

(4,094

)

1,089

Change in operating assets and liabilities, net of effect of acquisitions:

经营资产和负债的变动，扣除收购的影响：

Accounts receivable, net

应收账款净额

(22,930

)

(23,968

)

Other current assets

其他流动资产

(15,629

)

(23,430

)

Other assets

其他资产

696

(1,436

)

Accounts payable and other accrued liabilities

应付账款和其他应计负债

(403,340

)

13,633

Accrued salaries and benefits

应计工资和福利

(25,024

)

(30,386

)

Other liabilities

其他负债

6,749

2,114

Net cash (used in) provided by operating activities

经营活动产生（使用）的现金净额

(321,285

)

44,408

Investing activities:

投资活动：

Cash paid for acquisitions, net of cash acquired

收购支付的现金，扣除收购现金

(50,353

)

—

Cash paid for capital expenditures

支付资本支出的现金

(142,410

)

(66,525

)

Proceeds from sale of property and equipment

出售财产和设备的收益

9,056

409

Other

其他

(907

)

(794

)

Net cash used in investing activities

用于投资活动的现金净额

(184,614

)

(66,910

)

Financing activities:

融资活动：

Borrowings on long-term debt

长期债务借款

350,000

—

Borrowings on revolving credit facility

循环信贷贷款借款

160,000

40,000

Principal payments on revolving credit facility

循环信贷的本金支付

(15,000

)

—

Principal payments on long-term debt

长期债务本金支付

(10,242

)

(5,313

)

Payment of debt issuance costs

支付债务发行成本

(1,518

)

—

Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises

回购股份用于代扣代缴工资税，扣除股票期权行使的收益

(1,013

)

(47,671

)

Contributions from noncontrolling partners in joint ventures

合资企业中非控股合伙人的出资

2,280

1,655

Distributions to noncontrolling partners in joint ventures

对合资企业中非控股合伙人的分配

(1,020

)

—

Other

其他

(358

)

Net cash provided by (used in) financing activities

融资活动产生（使用）的现金净额

483,129

(11,318

)

Net decrease in cash and cash equivalents

现金及现金等价物净减少额

(22,770

)

(33,820

)

Cash and cash equivalents at beginning of the period

期初现金及现金等价物

100,073

97,649

Cash and cash equivalents at end of the period

期末现金及现金等价物

77,303

63,829

Effect of acquisitions:

收购的影响：

Assets acquired, excluding cash

收购资产，不包括现金

55,309

—

Liabilities assumed

承担的负债

(3,456

)

—

Contingent consideration issued in connection with an acquisition

与收购相关的或有对价

(1,500

)

—

Cash paid for acquisitions, net of cash acquired

收购支付的现金，扣除收购现金

50,353

—

Acadia Healthcare Company, Inc.

阿卡迪亚医疗保健公司。

Operating Statistics

运营统计

(Unaudited, Revenue in thousands)

（未经审计，收入以千计）

Three Months Ended March 31,

截至3月31日的三个月，

2024

2023

% Change

%更改

Same Facility Results (1)

相同的设施结果（1）

Revenue

收入

756,256

692,420

9.2

Patient Days

患者天数

757,990

741,711

2.2

Admissions

招生

48,158

49,006

-1.7

Average Length of Stay (2)

平均住院时间（2）

15.7

15.1

4.0

Revenue per Patient Day

每患者日收入

998

934

6.9

Adjusted EBITDA margin

调整后息税折旧摊销前利润率

28.7

27.5

120 bps

120个基点

Facility Results

设施结果

Revenue

收入

768,051

704,267

9.1

Patient Days

患者天数

768,678

754,858

1.8

Admissions

招生

49,058

49,906

-1.7

Average Length of Stay (2)

平均住院时间（2）

15.7

15.1

3.6

Revenue per Patient Day

每患者日收入

999

933

7.1

Adjusted EBITDA margin

调整后息税折旧摊销前利润率

27.5

26.5

100 bps

100个基点

(1) Same facility results for the periods presented include facilities we have operated for more than one year and exclude certain closed services.

（1）所列期间的相同授信结果包括我们运营了一年以上的授信，不包括某些封闭服务。

(2) Average length of stay is defined as patient days divided by admissions.

（2）平均住院时间定义为患者天数除以入院时间。

Acadia Healthcare Company, Inc.

阿卡迪亚医疗保健公司。

Reconciliation of Net Income Attributable to Acadia Healthcare Company, Inc. to Adjusted EBITDA

将归属于Acadia Healthcare Company，Inc.的净收入调整为调整后的息税折旧摊销前利润

(Unaudited)

（未经审计）

Three Months Ended March 31,

截至3月31日的三个月，

2024

2023

(in thousands)

（单位：千）

Net income attributable to Acadia Healthcare Company, Inc.

归属于Acadia Healthcare Company，Inc.的净收入。

76,383

66,015

Net income attributable to noncontrolling interests

归属于非控股权益的净收入

2,387

543

Provision for income taxes

所得税准备金

20,074

19,085

Interest expense, net

利息支出净额

27,214

19,999

Depreciation and amortization

折旧和摊销

36,347

31,569

EBITDA

162,405

137,211

Adjustments:

调整：

Equity-based compensation expense (a)

股权薪酬费用（a）

8,678

7,629

Transaction, legal and other costs (b)

交易、法律和其他费用（b）

2,847

6,471

Adjusted EBITDA

调整后息税折旧摊销前利润

173,930

151,311

Adjusted EBITDA margin

调整后息税折旧摊销前利润率

22.6

21.5

See footnotes on page 11.

见第11页脚注。

Acadia Healthcare Company, Inc.

阿卡迪亚医疗保健公司。

Reconciliation of Net Income Attributable to Acadia Healthcare Company, Inc. to

将归属于Acadia Healthcare Company，Inc.的净收入调节至

Adjusted Income Attributable to Acadia Healthcare Company, Inc.

归属于Acadia Healthcare Company，Inc.的调整后收入。

(Unaudited)

（未经审计）

Three Months Ended March 31,

截至3月31日的三个月，

2024

2023

(in thousands, except per share amounts)

（单位：千，每股金额除外）

Net income attributable to Acadia Healthcare Company, Inc.

归属于Acadia Healthcare Company，Inc.的净收入。

76,383

66,015

Adjustments to income:

收入调整：

Transaction, legal and other costs (b)

交易、法律和其他费用（b）

2,847

6,471

Provision for income taxes

所得税准备金

20,074

19,085

Adjusted income before income taxes attributable to Acadia Healthcare Company, Inc.

归属于Acadia Healthcare Company，Inc.的所得税前调整收入。

99,304

91,571

Income tax effect of adjustments to income (c)

收入调整的所得税影响（c）

22,011

22,920

Adjusted income attributable to Acadia Healthcare Company, Inc.

归属于Acadia Healthcare Company，Inc.的调整后收入。

77,293

68,651

Weighted-average shares outstanding - diluted

加权平均流通股-稀释

92,010

91,391

Adjusted income attributable to Acadia Healthcare Company, Inc. per diluted share

每股摊薄后归属于Acadia Healthcare Company，Inc.的调整后收入

0.84

0.75

See footnotes on page 11.

见第11页脚注。

Acadia Healthcare Company, Inc.

阿卡迪亚医疗保健公司。

Footnotes

脚注

We have included certain financial measures in this press release, including those listed below, which are “non-GAAP financial measures” as defined under the rules and regulations promulgated by the SEC. These non-GAAP financial measures include, and are defined, as follows:

我们在本新闻稿中纳入了某些财务措施，包括以下所列的财务措施，这些措施是美国证券交易委员会颁布的规则和法规中定义的“非公认会计准则财务措施”。这些非公认会计准则财务措施包括并定义如下：

• EBITDA: net income attributable to Acadia Healthcare Company, Inc. adjusted for net income attributable to noncontrolling interests, provision for income taxes, net interest expense and depreciation and amortization.

•息税折旧摊销前利润：归属于Acadia Healthcare Company，Inc.的净收入，根据归属于非控股权益的净收入、所得税准备金、净利息支出以及折旧和摊销进行调整。

• Adjusted EBITDA: EBITDA adjusted for equity-based compensation expense and transaction, legal and other costs.

•调整后的息税折旧摊销前利润：根据股权补偿费用和交易、法律和其他成本调整的息税折旧摊销前利润。

• Adjusted EBITDA margin: Adjusted EBITDA divided by revenue.

•调整后的息税折旧摊销前利润率：调整后的息税折旧摊销前利润除以收入。

• Adjusted income before income taxes attributable to Acadia Healthcare Company, Inc.: net income attributable to Acadia Healthcare Company, Inc. adjusted for transaction, legal and other costs and provision for income taxes.

•归属于Acadia Healthcare Company，Inc.的所得税前调整后收入：归属于Acadia Healthcare Company，Inc.的净收入，根据交易、法律和其他成本以及所得税准备金进行了调整。

• Adjusted income attributable to Acadia Healthcare Company, Inc.: Adjusted income before income taxes attributable to Acadia Healthcare Company, Inc. adjusted for the income tax effect of adjustments to income.

•归属于Acadia Healthcare Company，Inc.的调整后收入：归属于Acadia Healthcare Company，Inc.的所得税前调整后收入，根据收入调整的所得税影响进行调整。

• Net leverage ratio: Long-term debt (excluding $11.2 million of unamortized debt issuance costs, discount and premium) less cash and cash equivalents divided by Adjusted EBITDA for the trailing twelve months.

•净杠杆率：长期债务（不包括1120万美元的未摊销债务发行成本、折扣和溢价）减去现金和现金等价物，再除以随后12个月的调整后息税折旧摊销前利润。

The non-GAAP financial measures presented herein are supplemental measures of our performance and are not required by, or presented in accordance with, generally accepted accounting principles in the United States (“GAAP”). The non-GAAP financial measures presented herein are not measures of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP or as an alternative to cash flow from operating activities as measures of our liquidity.

本文所述的非公认会计准则财务指标是我们业绩的补充指标，不是美国公认会计准则（“GAAP”）所要求的，也不是根据美国公认会计准则（“GAAP”）提出的。本文所述的非GAAP财务指标不是根据GAAP衡量我们财务业绩的指标，不应被视为净收入或根据GAAP得出的任何其他业绩指标的替代指标，也不应被视为经营活动现金流的替代指标，以衡量我们的流动性。

Our measurements of these non-GAAP financial measures may not be comparable to similarly titled measures of other companies. We have included information concerning the non-GAAP financial measures in this press release because we believe that such information is used by certain investors as measures of a company’s historical performance.

我们对这些非GAAP财务指标的衡量可能无法与其他公司类似标题的指标进行比较。我们在本新闻稿中纳入了有关非公认会计准则财务指标的信息，因为我们认为这些信息被某些投资者用作衡量公司历史业绩的指标。

We believe these measures are frequently used by securities analysts, investors and other interested parties in the evaluation of issuers of equity securities, many of which present similar non-GAAP financial measures when reporting their results. Because the non-GAAP financial measures are not measurements determined in accordance with GAAP and are thus susceptible to varying calculations, the non-GAAP financial measures, as presented, may not be comparable to other similarly titled measures of other companies.

我们认为，证券分析师、投资者和其他利益相关方在评估权益证券发行人时经常使用这些指标，其中许多在报告业绩时采用类似的非公认会计原则财务指标。由于非公认会计原则财务指标不是根据公认会计原则确定的指标，因此容易受到不同计算的影响，因此所提出的非公认会计原则财务指标可能无法与其他公司的其他类似标题的指标进行比较。

Our presentation of these non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items..

我们对这些非公认会计准则财务指标的表述不应被解释为推断我们的未来结果将不受异常或非经常性项目的影响。。

The Company is not able to provide a reconciliation of projected Adjusted EBITDA and adjusted earnings per diluted share, where provided, to expected results due to the unknown effect, timing and potential significance of transaction-related expenses and the tax effect of such expenses.

由于交易相关费用的未知影响、时间安排和潜在重要性以及此类费用的税务影响，本公司无法提供预期调整后息税折旧摊销前利润和稀释每股调整后收益与预期结果的对账。

(a) Represents the equity-based compensation expense of Acadia.

（a）代表Acadia基于股权的薪酬支出。

(b) Represents transaction, legal and other costs incurred by Acadia primarily related to legal, management transition, termination, restructuring, acquisition and other similar costs.

（b）代表Acadia产生的交易、法律和其他成本，主要与法律、管理层过渡、终止、重组、收购和其他类似成本有关。

(c) Represents the income tax effect of adjustments to income based on tax rates of 22.2% and 25.0% for the three months ended March 31, 2024 and 2023, respectively.

（c）代表截至2024年和2023年3月31日的三个月内，分别基于22.2%和25.0%的税率对收入进行调整的所得税影响。

全球产业链接平台

重庆市渝北区金星科技大厦A区5楼512室

联系电话：023-67139735（重庆）

关于我们

产品服务